Scientific publisher Nature Publishing Group (NPG), UK, will be the official media partner for 2010 WIN (Worldwide Innovative Networking) Symposium, it has been announced. The WIN Consortium is a joint initiative of the Institut Gustave Roussy (France) and the University of Texas M. D. Anderson Cancer Center (USA), in association with several other leading cancer care institutions in the US, Europe, Canada and Asia.
The second annual WIN Symposium, which will be held in the Palais des Congrès, Paris, July 7–9, 2010, is expected to bring together hundreds of oncology researchers from around the world to discuss how best to tailor therapies for patients with cancer. As part of the media partnership, NPG will showcase breakthrough scientific technologies and achievements in personalised cancer medicine in a focus issue to be published in Nature Reviews Clinical Oncology. This special edition of the journal, which will be published early in 2011, will feature reviews written by prominent members of the WIN Consortium who will be leading the discussion at this year’s symposium.
It has been observed that clinical researchers, working in academia and the pharmaceutical industry, are starting to make real progress in understanding tumor pathology and identifying which patients will respond best to particular treatments. The WIN Consortium seeks to aid the rapid translation of personalised cancer medicine discoveries from the bench to the bedside. Led by WIN Consortium President, Professor John Mendelsohn of the University of Texas MD Anderson Cancer Center, this organisation is new cooperation between academia and the pharmaceutical industry.
Search for more Conferences
